By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
UPDATE: Stride says 'stapled structure' protects PIE status while funds management grows
Major investor Devon slashes stake in Tower Insurance
Tiwai Point smelter's earnings plunge in second half of financial year
3pm embargo: NZ sharemilking farmers, pressured by low prices, are least happy with their bank, survey shows
Fat Prophet's Hot Stock: Sonic Healthcare (SHL.ASX)
Good NZ directors too wary of joining SME boards, FMA's Everett says
Speirs Group calls special meeting to vote on Unlisted move as NZAX winds down
RMA reform bill delayed two months as select committee seeks extension
US private equity firm Blackstone takes minority stake in Partners Life with $200 mln investment
UIL buys shares in wave technology developer Carnegie Wave Energy